SANKYO C25 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)

Pill with imprint SANKYO C25 is Pink, Elliptical / Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANKYO C25

Hydrochlorothiazide and Olmesartan Medoxomil

Imprint

SANKYO C25

Strength

25 mg / 40 mg

Color

Pink

Size

15.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Angiotensin II inhibitors with thiazides

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Sun Pharmaceutical Industries Inc.

Labelers / Repackagers

NDC Code	Labeler / Repackager
57664-0760	Caraco Pharmaceutical Laboratories, Ltd.
65597-0107	Daiichi Sankyo
54868-5078	Physicians Total Care Inc. (repackager)
54569-5903	A-S Medication Solutions, LLC (repackager)
55289-0443	PDRX Pharmaceuticals Inc. (repackager)
35356-0258	Lake Erie Medical and Surgical Supply (repackager)
35356-0289	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "SANKYO C25"

Benicar HCT

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer